STM publisher Elsevier and the International Association for the Study of Lung Cancer (IASLC) have jointly announced Elsevier's appointment as publisher of the IASLC's official journal, Journal of Thoracic Oncology (JTO), beginning January 2016.
Published since 2006, the Journal of Thoracic Oncology emphasizes a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews, and opinion pieces. This peer-reviewed journal is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. It has a global author base and readership comprising epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.
Researchers, academic physicians, clinicians, and the libraries that serve them will have increased access to cutting-edge research through Elsevier's sophisticated online channels, which offer readers enhanced features and expanded discoverability, while authors benefit from seamless and easy dissemination of their important work.
With a significant Impact Factor of 5.282, JTO is ranked 30th out of 211 journals in Oncology and 7th out of 57 journals in Respiratory Medicine. Managing Editor Mary Sharkey Todd will continue to provide support and guidance to the JTO and IASLC community.
Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
